EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner

Gabriel Chamberlain, Guillaume L Lopez, Léa Bourguignon, Xavier Laulhé, Yasmine Adda-Bouchard, Tania Charpentier, Rebekah Honce, Jason W Botten, Alain Lamarre iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Gabriel Chamberlain und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunovirology Laboratory, Institut national de la recherche scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada. Hauptthemen laut MEDLINE: B-Lymphocytes, Lymphocytic choriomeningitis virus, Antigen Presentation, Antigens, Viral. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The polyclonal, T-dependent nature of hypergammaglobulinemia during murine infection with LCMV is well defined, however the mechanism by which polyclonal B cells acquire antigens for presentation remains unknown. Here we use LCMV-specific CD4 + transgenic T cells to explore several hypotheses for B cell antigen uptake. We found that antigens produced by cells infected with LCMV in vitro are available to polyclonal B cells and their presentation to CD4+ T cells enabled robust co-activation. The in vitro nature of our model demonstrates that in vivo factors such as cytokine milieu and antigen release by NK/CD8+ are not required. We show that non-replicative UVC-irradiated LCMV enables antigen access to B cells, thus productive infection of B cells is not required for antigen acquisition. B cells loaded with LCMV antigens in vitro can efficiently present these antigens to CD4+ T cells in LCMV-infected mice, thereby validating our model in vivo . Using transmission electron microscopy we identified LCMV-GP bearing particles of various sizes including

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesLymphocytic choriomeningitis virusAntigen PresentationAntigens, ViralLymphocytic ChoriomeningitisAnimalsMiceMice, TransgenicCD4-Positive T-LymphocytesMice, Inbred C57BLLymphocyte Activation

Substanzen

Antigens, Viral

Autor:innen und Institutionen

  • Immunovirology Laboratory, Institut national de la recherche scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.
  • Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.

ORCID-Profile: Alain Lamarre

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • Canadian Institutes for Health Research

Zitieren

APA

Chamberlain, G., Lopez, G. L., Bourguignon, L., Laulhé, X., Adda-Bouchard, Y., Charpentier, T., Honce, R., Botten, J. W., & Lamarre, A. (2025). Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013345

Vancouver

Chamberlain G, Lopez GL, Bourguignon L, Laulhé X, Adda-Bouchard Y, Charpentier T, et al. Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013345

BibTeX
@article{Chamberlain2025,
  author = {Chamberlain, Gabriel and Lopez, Guillaume L and Bourguignon, Léa and Laulhé, Xavier and Adda-Bouchard, Yasmine and Charpentier, Tania and Honce, Rebekah and Botten, Jason W and Lamarre, Alain},
  title = {Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013345}
}
Kostenlos starten →